Association of DLG5 variants with inflammatory bowel disease in the New Zealand caucasian population and meta‐analysis of the DLG5 R30Q variant

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Inflammatory Bowel Diseases

• Publication date

  2007-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ibd.20157PMID 17455201
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Investigation of association of the DLG5 gene with phenotypes of inflammatory bowel disease in the British population

  2007cited by this paper
• Role of discs large homolog 5.

  2006cited by this paper
• An utter refutation of the ‘Fundamental Theorem of the HapMap’

  2006cited by this paper
• Direct or indirect association in a complex disease: the role of SLC22A4 and SLC22A5 functional variants in Crohn disease

  2006cited by this paper
• High incidence of Crohn's disease in Canterbury, New Zealand: Results of an epidemiologic study

  2006cited by this paper
• Association of DLG5 and inflammatory bowel disease across populations

  2006cited by this paper
• Relationship between CARD15, SLC22A4/5, and DLG5 polymorphisms and early-onset inflammatory bowel diseases: an Italian multicentric study.

  2006cited by this paper
• DLG5 Variants in Inflammatory Bowel Disease

  2006cited by this paper
• Evidence of transmission ratio distortion of DLG5 R30Q variant in general and implication of an association with Crohn disease in men

  2006cited by this paper
• DLG5 variants contribute to Crohn disease risk in a Canadian population

  2006cited by this paper
• DLG5 R30Q is not associated with IBD in Hungarian IBD patients but predicts clinical response to steroids in Crohn's disease.

  2006cited by this paper
• Genetic variants in TNF‐&agr; but not DLG5 are associated with inflammatory bowel disease in a large United Kingdom cohort

  2006cited by this paper
• Extreme heterogeneity in CARD15 and DLG5 Crohn disease-associated polymorphisms between German and Norwegian populations

  2006cited by this paper
• Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.

  2005cited by this paper
• DLG5 variants do not influence susceptibility to inflammatory bowel disease in the Scottish population

  2005cited by this paper
• A note on exact tests of Hardy-Weinberg equilibrium.

  2005cited by this paper
• Single nucleotide polymorphisms of OCTN1, OCTN2, and DLG5 genes in Greek patients with Crohn's disease.

  2005cited by this paper
• Genetics of Crohn disease, an archetypal inflammatory barrier disease

  2005cited by this paper
• Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD.

  2005cited by this paper
• Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn’s disease

  2005cited by this paper
• Association of DLG5 R30Q variant with inflammatory bowel disease

  2005cited by this paper
• Differential Effects of NOD2 Variants on Crohn's Disease Risk and Phenotype in Diverse Populations: A Metaanalysis

  2004cited by this paper
• Association analysis of SLC22A4, SLC22A5 and DLG5 in Japanese patients with Crohn disease

  2004cited by this paper
• Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs.

  2004cited by this paper
• Genetics of inflammatory bowel disease: progress and prospects.

  2004cited by this paper
• Genetic variation in DLG5 is associated with inflammatory bowel disease

  2004cited by this paper
• NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe?

  2004cited by this paper
• Analysis of the IBD5 locus and potential gene-gene interactions in Crohn’s disease

  2003cited by this paper
• Pedigree disequilibrium tests for multilocus haplotypes

  2003cited by this paper
• Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn disease.

  2003cited by this paper
• IBD5 is a general risk factor for inflammatory bowel disease: replication of association with Crohn disease and identification of a novel association with ulcerative colitis.

  2003cited by this paper
• A haplotype map of the human genome

  2003cited by this paper
• A haplotype map of the human genome.

  2003cited by this paper
• The cloning, genomic organization and tissue expression profile of the human DLG5 gene

  2002cited by this paper
• Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease

  2001cited by this paper
• Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

  2001cited by this paper
• A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

  2001cited by this paper
• Automated Mass Spectrometry: A Revolutionary Technology for Clinical Diagnostics

  2000cited by this paper
• Concordance of Inflammatory Bowel Disease among Danish Twins: Results of a Nationwide Study

  2000cited by this paper
• Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study.

  2000cited by this paper
• A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort.

  1999cited by this paper
• Identification of a novel human homolog of the Drosophila dlg, P‐dlg, specifically expressed in the gland tissues and interacting with p55

  1998cited by this paper
• The significance of haemochromatosis gene mutations in the general population: implications for screening.

  1998cited by this paper
• From genotypes to genes: doubling the sample size.

  1997cited by this paper
• Prevalence and family risk of ulcerative colitis and Crohn's disease: an epidemiological study among Europeans and south Asians in Leicestershire.

  1993cited by this paper
• Familial aggregation of inflammatory bowel disease in northern Italy: a multicenter study. The Gruppo di Studio per le Malattie Infiammatorie Intestinali (IBD Study Group).

  1992cited by this paper
• Familial occurrence of inflammatory bowel disease.

  1991cited by this paper
• Classification of inflammatory bowel disease.

  1989cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper
• The combination of estimates from different experiments.

  1954cited by this paper

• A Systematic Review on the Increasing Incidence of Inflammatory Bowel Disease in Southeast Asia: Looking Beyond the Urbanization Phenomenon.

  2023cites this paper
• Inflammatory bowel disease: why this provides a useful example of the evolving science of nutrigenomics

  2020influential citation
• Discs Large Homolog 5 (DLG5) Gene Polymorphism and Crohn's Disease: A Meta-Analysis of the Published Studies.

  2016cites this paper
• Meta-analysis of associations between DLG5 R30Q and P1371Q polymorphisms and susceptibility to inflammatory bowel disease

  2016cites this paper
• The association of DLG5 polymorphisms with inflammatory bowel disease: a meta-analysis of 25 studies.

  2016cites this paper
• Systematic meta-analyses and field synopsis of genetic and epigenetic studies in paediatric inflammatory bowel disease

  2016cites this paper
• Asia Pacific Consensus Statements on Crohn's disease. Part 1: Definition, diagnosis, and epidemiology

  2016cites this paper
• Genetic polymorphism in ATG16L1 gene influences the response to adalimumab in Crohn's disease patients.

  2015cites this paper
• Genetic susceptibility and genotype-phenotype association in 588 Danish children with inflammatory bowel disease.

  2014cites this paper
• Nutrigenetics and Crohn’s Disease

  2013cites this paper
• Single-nucleotide polymorphisms in inflammatory bowel disease.

  2012cites this paper
• Varianten im DLG5-Gen und deren Einfluss auf Entstehung und Verlauf chronisch entzündlicher Darmerkrankungen

  2012cites this paper
• Pharmacogenomics of Inflammatory Bowel Diseases

  2012cites this paper
• Identification of DLG 5 and SLC 22 A 5 gene polymorphisms in Malaysian patients with Crohn ’ s disease

  2011cites this paper
• DLG5 P1371Q is associated with inflammatory bowel disease and complementary to R30Q in disease susceptibility.

  2011cites this paper
• Tailoring Foods to Match People’s Genes in New Zealand: Opportunities for Collaboration

  2011cites this paper
• Investigation of the phenotypic and genotypic determinants of disease susceptibility and progression in Crohn’s Disease

  2011cites this paper
• Identification of DLG5 and SLC22A5 gene polymorphisms in Malaysian patients with Crohn's disease

  2011cites this paper
• Chronic inflammation and mutagenesis.

  2010cites this paper
• Characterization of single‐nucleotide polymorphisms relevant to inflammatory bowel disease in commonly used gastrointestinal cell lines

  2010cites this paper
• Interaction of Crohn's Disease Susceptibility Genes in an Australian Paediatric Cohort

  2010cites this paper
• Identification of novel genetic determinants in the high prevalence early-onset inflammatory bowel disease population in Scotland

  2010cites this paper
• The Effects of Kiwifruit Extracts on Gene and Protein Expression Levels in In Vitro and In Vivo Mouse Models of Inflammatory Bowel Disease

  2010cites this paper
• Tailoring foods to match people's genes in New Zealand: opportunities for collaboration.

  2010cites this paper
• Tumor Necrosis Factor Receptor Superfamily, Member 1B Haplotypes Increase or Decrease the Risk of Inflammatory Bowel Diseases in a New Zealand Caucasian Population

  2009cites this paper
• Genetic Association of DLG5 R30Q with Familial and Sporadic Inflammatory Bowel Disease in Men

  2009cites this paper
• Research progress in susceptible genes of inflammatory bowel disease

  2009cites this paper
• The genetics of Crohn's disease.

  2009cites this paper
• Nucleotide-binding oligomerization domain containing 1 (NOD1) haplotypes and single nucleotide polymorphisms modify susceptibility to inflammatory bowel diseases in a New Zealand caucasian population: a case-control study

  2009cites this paper
• The Genetics of Inflammatory Bowel Disease

  2007cites this paper
• Gender-stratified analysis of DLG5 R30Q in 4707 patients with Crohn disease and 4973 controls from 12 Caucasian cohorts

  2007cites this paper
• Genes, diet and inflammatory bowel disease.

  2007cites this paper
• DLG 5 P 1371 Q is associated with inflammatory bowel disease and complementary to R 30 Q in disease susceptibility

  year unknowncites this paper